SG11201503215XA - Novel method for treating spinal cord injury using hmgb1 fragment - Google Patents

Novel method for treating spinal cord injury using hmgb1 fragment

Info

Publication number
SG11201503215XA
SG11201503215XA SG11201503215XA SG11201503215XA SG11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA
Authority
SG
Singapore
Prior art keywords
spinal cord
novel method
cord injury
treating spinal
hmgb1 fragment
Prior art date
Application number
SG11201503215XA
Other languages
English (en)
Inventor
Katsuto Tamai
Takehiko Yamazaki
Wenhao Cui
Original Assignee
Genomix Co Ltd
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomix Co Ltd, Univ Osaka filed Critical Genomix Co Ltd
Publication of SG11201503215XA publication Critical patent/SG11201503215XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201503215XA 2012-10-25 2013-10-24 Novel method for treating spinal cord injury using hmgb1 fragment SG11201503215XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012235786 2012-10-25
PCT/JP2013/078759 WO2014065348A1 (fr) 2012-10-25 2013-10-24 Nouveau procédé de traitement d'une lésion de la moelle épinière à l'aide d'un fragment hmgb1

Publications (1)

Publication Number Publication Date
SG11201503215XA true SG11201503215XA (en) 2015-06-29

Family

ID=50544721

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503215XA SG11201503215XA (en) 2012-10-25 2013-10-24 Novel method for treating spinal cord injury using hmgb1 fragment

Country Status (18)

Country Link
US (1) US9688733B2 (fr)
EP (1) EP2913059B1 (fr)
JP (1) JP6253590B2 (fr)
KR (1) KR102146822B1 (fr)
CN (1) CN104955470B (fr)
AU (1) AU2013335685B2 (fr)
BR (1) BR112015008745B1 (fr)
CA (1) CA2889299C (fr)
DK (1) DK2913059T3 (fr)
ES (1) ES2673861T3 (fr)
HK (2) HK1212888A1 (fr)
MX (1) MX365899B (fr)
PL (1) PL2913059T3 (fr)
RU (1) RU2649069C2 (fr)
SG (1) SG11201503215XA (fr)
TR (1) TR201807769T4 (fr)
WO (1) WO2014065348A1 (fr)
ZA (1) ZA201502829B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9919010B2 (en) 2008-04-30 2018-03-20 Genomix Co., Ltd. Method for collecting functional cells in vivo with high efficiency
PT3358011T (pt) 2011-04-26 2020-04-23 Univ Osaka Péptido para induzir a regeneração de um tecido e a sua utilização
SG11201503236RA (en) 2012-10-25 2015-06-29 Genomix Co Ltd Novel method for treating cardiac infarction using hmgb1 fragment
BR112019014921A2 (pt) 2017-01-27 2020-03-31 StemRIM Inc. Agente terapêutico para miocardiopatia, infarto antigo do miocárdio e insuficiência cardíaca crônica
US11298403B2 (en) 2017-12-01 2022-04-12 StemRIM Inc. Therapeutic agent for inflammatory bowel disease
WO2019156137A1 (fr) 2018-02-08 2019-08-15 株式会社ステムリム Agent thérapeutique contre le psoriasis
BR112021005982A2 (pt) * 2018-10-05 2021-06-29 StemRIM Inc. peptídeo possuindo atividade de mobilização de células-tronco mesenquimais
CN113423466A (zh) * 2018-10-25 2021-09-21 国立大学法人大阪大学 软骨病症的治疗剂

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5238680B2 (fr) 1972-12-27 1977-09-30
US5658894A (en) 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5661127A (en) 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
JP3018313B2 (ja) 1996-02-23 2000-03-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
JP2003505506A (ja) 1999-07-28 2003-02-12 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 幹細胞と前駆細胞のリクルートメントにおけるニコチン受容体アゴニスト
EP1114862A3 (fr) 1999-11-17 2003-08-06 Switch Biotech Aktiengesellschaft Utilitsation des polypeptides ou leurs acids nucléiques pour la diagnose ou traitement des maladies de la peau et leurs utilisation pour l'identification des substances pharmacologiquement actives
DK1257632T3 (da) 2000-02-24 2008-01-28 Xcyte Therapies Inc Samtidig stimulering og opkoncentrering af celler
JP3421741B2 (ja) 2000-05-18 2003-06-30 筑波大学長 人工骨髄、血球細胞の増殖方法
US20040191246A1 (en) 2003-02-26 2004-09-30 Connelly Patrick R. Process for in vivo treatment of specific biological targets in bodily fluid
ITMI20010562A1 (it) 2001-03-16 2002-09-16 Marco E Bianchi Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari
DE10121254A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
AU2002304710A1 (en) 2001-04-30 2002-11-11 Switch Biotech Ag Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
US20030060410A1 (en) 2001-05-15 2003-03-27 North Shore Long Island Jewish Research Institute Use of HMG fragments as anti-inflammatory agents
ITMI20011986A1 (it) 2001-09-25 2003-03-25 San Raffaele Centro Fond Metodo e composizione per l'attivazione di cellule presentanti l'antigene
EP1459759A4 (fr) 2001-11-19 2007-08-29 Kyowa Hakko Kogyo Kk Medicament mobilisant les cellules souches totipotentes d'un tissu dans le sang peripherique
US20030161816A1 (en) 2001-12-07 2003-08-28 Fraser John K. Systems and methods for treating patients with processed lipoaspirate cells
CN1671742A (zh) 2002-07-03 2005-09-21 塔博尔山圣拉弗尔基金中心 Hmgb1在治疗组织损伤和/或促进组织修复中的用途
DE60327075D1 (de) 2002-07-05 2009-05-20 Univ Laval Der entzündungsreaktionen
GB0226251D0 (en) 2002-11-11 2002-12-18 San Raffaele Centro Fond Acetylated protein
CA2506328A1 (fr) 2002-11-20 2004-06-03 Critical Therapeutics, Inc. Utilisation de fragments hmgb en tant qu'agents anti-inflammatoires
US20070154529A1 (en) 2003-01-03 2007-07-05 Alcedo Biotech Gmbh Uses of dna binding proteins
WO2004084928A1 (fr) 2003-03-28 2004-10-07 UNIVERSITé LAVAL Proteine s100 utilisee en tant qu'activateur des neutrophiles pour attenuer la neutropenie dans le traitement du cancer
US20050014255A1 (en) 2003-05-29 2005-01-20 Board Of Regents, The University Of Texas System Stem cells for clinical and commercial uses
WO2005025604A2 (fr) 2003-09-10 2005-03-24 The General Hospital Corporation Utilisation de hmgb et fragments de hmgb pour faire diminuer la reponse immunitaire specifique
ITRM20040058A1 (it) 2004-02-03 2004-05-03 Marco E Bianchi Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
EP1768693A1 (fr) 2004-07-20 2007-04-04 Provincia Italiana Della Congregazione Dei Figli Dell'Immacolata Concezione - Istituto Dermopatico Dell'Immacolata Utilisation de hmgb1 dans la cicatrisation des plaies
MX2007001155A (es) 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
MX2007002557A (es) 2004-09-03 2007-10-10 Creabilis Therapeutics Spa Uso de polipeptidos obtenidos a traves de mutaciones sistematicas de aminoacidos unicos de bloque-a humano y no humano de hmgb1 para prevenir y/o antagonizar las patologias inducidas por hmgb1.
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 p 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
WO2006047820A1 (fr) 2004-11-01 2006-05-11 Newsouth Innovations Pty Limited Utilisation de la calgranuline a et b pour la stimulation et l'inhibition de la formation de tissus mineralises
ITRM20050032A1 (it) 2005-01-21 2006-07-22 Marco E Bianchi Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
JP5103626B2 (ja) 2005-01-27 2012-12-19 財団法人ヒューマンサイエンス振興財団 間葉系幹細胞を含む細胞シート
MX2007011218A (es) 2005-03-23 2007-10-17 Biosafe Sa Sistema integrado para colectar, procesar y transplantar subconjuntos de celulas, incluyendo celulas madre adultas para medicina regenerativa.
WO2006114805A2 (fr) 2005-04-28 2006-11-02 Fondazione Centro San Raffaele Del Monte Tabor Utilisation des proteines hmgb2 et hmgb3 pour applications medicales
WO2007015546A1 (fr) 2005-08-04 2007-02-08 Genomix Co., Ltd Inducteur de cellules souches mésenchymales, promoteur de régénération tissulaire et méthode de préparation de cellules souches mésenchymales
WO2007031100A1 (fr) 2005-09-14 2007-03-22 Ostini, Marco Immunothérapie active pour inflammation systémique potentiellement mortelle
WO2007130725A2 (fr) 2006-02-06 2007-11-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Utilisation de hmgb1 en protection contre les lésions de reperfusion de l'ischémie
JP4982739B2 (ja) 2006-06-01 2012-07-25 国立大学法人 東京医科歯科大学 ポリグルタミン病の予防・治療剤
ES2396220T3 (es) 2006-08-11 2013-02-20 Ono Pharmaceutical Co., Ltd. Anticuerpos monoclonales frente al factor 1 derivado del estroma (SDF-1)
DK2055308T3 (en) 2006-10-30 2017-07-17 Genomix Co Ltd PHARMACEUTICALS FOR PROMOTING FUNCTIONAL REGENERATION OF DAMAGED TISSUE
US9919010B2 (en) 2008-04-30 2018-03-20 Genomix Co., Ltd. Method for collecting functional cells in vivo with high efficiency
US8673580B2 (en) 2008-04-30 2014-03-18 Genomix Co., Ltd. Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
RU2010148785A (ru) * 2008-04-30 2012-06-10 Дженомикс Ко., Лтд. (Jp) Фармацевтическое средство для стимуляции функциональной регенерации поврежденной ткани
JP2013508013A (ja) * 2009-10-16 2013-03-07 ザ ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 細胞療法戦略を用いた慢性神経組織損傷の治療方法
CN102711777B (zh) 2009-10-28 2015-04-15 吉诺米克斯股份有限公司 利用骨髓间充质干细胞和/或多能干细胞的血中动员的组织再生促进剂
PT3358011T (pt) 2011-04-26 2020-04-23 Univ Osaka Péptido para induzir a regeneração de um tecido e a sua utilização
CN102443064A (zh) 2011-11-03 2012-05-09 刘誉 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
SG11201503236RA (en) 2012-10-25 2015-06-29 Genomix Co Ltd Novel method for treating cardiac infarction using hmgb1 fragment

Also Published As

Publication number Publication date
US9688733B2 (en) 2017-06-27
CN104955470A (zh) 2015-09-30
TR201807769T4 (tr) 2018-06-21
ES2673861T3 (es) 2018-06-26
MX2015005253A (es) 2015-10-29
BR112015008745A2 (pt) 2017-11-21
CN104955470B (zh) 2017-06-16
JPWO2014065348A1 (ja) 2016-09-08
EP2913059B1 (fr) 2018-04-11
ZA201502829B (en) 2020-11-25
HK1213201A1 (zh) 2016-06-30
JP6253590B2 (ja) 2017-12-27
EP2913059A1 (fr) 2015-09-02
WO2014065348A1 (fr) 2014-05-01
RU2015119523A (ru) 2016-12-20
MX365899B (es) 2019-06-19
KR102146822B1 (ko) 2020-08-21
RU2649069C2 (ru) 2018-04-02
PL2913059T3 (pl) 2018-09-28
EP2913059A4 (fr) 2016-03-30
HK1212888A1 (zh) 2016-06-24
US20150274792A1 (en) 2015-10-01
AU2013335685A1 (en) 2015-05-14
CA2889299A1 (fr) 2014-05-01
AU2013335685B2 (en) 2017-10-12
KR20150102957A (ko) 2015-09-09
DK2913059T3 (en) 2018-06-25
BR112015008745B1 (pt) 2022-08-02
CA2889299C (fr) 2023-02-14

Similar Documents

Publication Publication Date Title
HK1244502A1 (zh) 用於治療輻射或化學傷的方法
HK1212887A1 (zh) 利用 片段的治療心肌梗塞的新型方法
HK1213201A1 (zh) 利用了 片段的針對脊髄損傷的新型治療方法
HK1186748A1 (zh) 烴處理工藝
ZA201906339B (en) Methods for treating pruritus
IL227768A0 (en) Brain injury treatment methods
ZA201208219B (en) Method for treating wasterwater
IL225623A0 (en) Psoriasis treatment methods
EP2771505A4 (fr) Appareil de traitement de linge
EP2731556A4 (fr) Méthodes et appareils de traitement de fractures vertébrales
SG11201505152PA (en) Method for inducing astrocytes
HUE050799T2 (hu) Berendezés szerves massza kezelésére
ZA201302579B (en) Apparatus for performing heat treatment
HK1202457A1 (en) Methods for treating parkinsons disease
EP2815014A4 (fr) Appareil de traitement du linge
EP2816126A4 (fr) Procédé de traitement thermique
GB2502133B (en) Treatment or therapeutic apparatus
EP2930152A4 (fr) Appareil de traitement de l'eau
KR102010981B9 (ko) 수처리장치
GB201204071D0 (en) Polymer treatment method
GB201205911D0 (en) Hair treatment method
EP2838456A4 (fr) Appareil et procédé de fixation d'apophyse épineuse
SG11201402604UA (en) Shipping-container-based ballast water treatment apparatus
HK1209040A1 (en) Methods for treating vestibulotoxicity
ZA201407215B (en) Method for emulsion treatment